PeRioperative Study of Exercise Training in Patients With Operable Cancer of the Gastroesophageal Junction
PRESET
1 other identifier
interventional
40
1 country
1
Brief Summary
Background: For patients diagnosed with operable cancer of the gastro-esophageal junction (GEJ), the perioperative course of therapy is associated with severe deconditioning which includes weight loss and poor physical function, which are strong predictor of post-surgical complication and survival . A strong rationale exists to explore how to develop supportive interventions aimed at maintaining/improving muscle function (lean body mass and muscle strength) during the pre-surgical phase. This study explores the safety, feasibility and efficacy of structured pre- and post-operative exercise training in patient undergoing surgery for cancer of the gastro-esophageal junction. Subjects: Patients with histologically verified, resectable adenocarcinoma of the GEJ scheduled for treatment af Rigshospitalet, Copenhagen, Denmark. Methods: In a case-control design, patients will be allocated to either an exercise training intervention group, or a usual-care observational group, based on geographical location. Forty patients will be included in this case-control study and allocated by geographical region as follows; 20 training intervention-cases living in the greater Copenhagen area, and 20 observational control subjects living outside the greater Copenhagen area. All patients will undergo a total of 5 assessments during the perioperative trajectory; twice prior to surgery (baseline and pre-surgery test), three post-surgery (2 week post- and 15 weeks post-surgery, and at 1-year follow-up). Assessments include measures of body composition by DXA scan and bioelectrical impedance analysis: systemic inflammation in fasting blood sample; quality of life by self-report questionnaires; physical function by handgrip strength and sit-to-stand test. As optional procedures, we will collect biological tissue from tumor, muscle and fat biopsies and a 10 ml blood sample at baseline and pre-surgery test only. Also, we will collect blood samples before, during and after an acute exercise bout exercise in order to explore the acute systemic changes in exercise-regulated biomarkers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2016
CompletedFirst Posted
Study publicly available on registry
March 30, 2016
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedAugust 15, 2018
August 1, 2018
1.5 years
March 10, 2016
August 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Recording of adverse events will be separated into two procedures: recordings during trial visits and recordings during exercise sessions. AE/SAE recording during trial assessment visits This procedure will concern any AE/SAE which can be attributed to study-related assessment procedures during the trial visits, i.e. discomfort during physical tests or blood sampling, which will be recorded immediately during the visit and recorded for the given visit. Also, for each trial visit we will collect patients' self-report of AE/SAEs, which may have occurred during the period since the last trial visit without our knowledge. AE/SAE recording during exercise sessions For every exercise session, a trained instructor will supervise the exercise program including recording of AE/SAEs during these session
Baseline to 1-year follow-up
Adherence to prescribed exercise program
Proportion of exercise sessions completed.
Baseline to 3 months post surgery
Secondary Outcomes (19)
Changes in fat percentage
Baseline to 1-year follow-up
Changes in lean mass
Baseline to 1-year follow-up
Changes in fat mass
Baseline to 1-year follow-up
Changes in Plasma Total-Cholesterol concentrations
Baseline to 1-year follow-up
Changes in Plasma LDL-Cholesterol concentrations
Baseline to 1-year follow-up
- +14 more secondary outcomes
Other Outcomes (1)
Tissue sampling - Optional
At baseline and at surgery
Study Arms (2)
Usual Care Observation Group
NO INTERVENTIONPatients allocated to usual care control will receive the standard patient care program as provided by the department of surgical gastroenterology, Rigshospitalet
Aerobic and Resistance Exercise Training
EXPERIMENTALPatients allocated to this group will receive usual care plus a supervised aerobic and resistance exercise program at CFAS' facilities consisting of 2 weekly sessions of approximately 60 minutes.
Interventions
Supervised aerobic and resistance exercise program consisting of 2 weekly sessions of approximately 60 minutes. Patients will perform a test of maximum cardio-respiratory (Watt-max test) and muscle strength (1 repetition maximum \[1-RM\] test) capacity. Using the patient's individual capacity score (Watt-max and 1RM), a personalized exercise program will be prescribed. After a light warm-up, patients will perform 20-30 min of aerobic interval training of stationary bicycle. Resistance training comprises 4 exercises for the major muscle groups: chest press, leg press, lateral pull, and knee extension with 3-4 sets of 8 to 15 repetitions. Each session will be supervised by trained instructors to ensure proper technique, and progression in training load.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with histologically verified, resectable adenocarcinoma of the GEJ.
You may not qualify if:
- Deemed in-operable at multidisciplinary medical conference
- Pregnancy
- Any other known malignancy requiring active treatment
- In-eligible to chemotherapy
- Performance status \> 1
- Physical disabilities precluding physical testing and/or exercise
- Inability to read and understand Danish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet
Copenhagen, 2100, Denmark
Related Publications (1)
Simonsen C, Thorsen-Streit S, Sundberg A, Djurhuus SS, Mortensen CE, Qvortrup C, Pedersen BK, Svendsen LB, de Heer P, Christensen JF. Effects of high-intensity exercise training on physical fitness, quality of life and treatment outcomes after oesophagectomy for cancer of the gastro-oesophageal junction: PRESET pilot study. BJS Open. 2020 Oct;4(5):855-864. doi: 10.1002/bjs5.50337. Epub 2020 Aug 28.
PMID: 32856785DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jesper F Christensen, PhD
Rigshospitalet, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
March 10, 2016
First Posted
March 30, 2016
Study Start
April 1, 2016
Primary Completion
October 1, 2017
Study Completion
May 1, 2018
Last Updated
August 15, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share